Adverse events
| Group 1 (n = 60) | Group 2 (n = 55) | ||
|---|---|---|---|
| Adverse events | 279 (n = 47, 78.3%) | 316 (n = 45, 81.8%) | 0.641 |
| Severe adverse events | 33 (n = 21, 35.0%) | 36 (n = 23, 41.8%) | 0.452 |
| Mycophenolate mofetil-related adverse events | 40 (n = 25, 41.7%) | 39 (n = 20, 36.4%) | 0.561 |
| Adverse drug reaction | 20 (n = 10, 16.7%) | 21 (n = 13, 23.6%) | 0.351 |
Group 1, steroid withdrawal at 2 weeks after transplantation; Group 2, steroid withdrawal at 3 months after transplantation.